ロード中...
Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with Asthma
INTRODUCTION: Benralizumab, an interleukin-5 receptor alpha–directed cytolytic anti-eosinophil monoclonal antibody, was recently approved as add-on maintenance treatment for patients aged 12 years and older with uncontrolled asthma with eosinophilic inflammation. METHODS: Pharmacokinetic (PK) data f...
保存先:
| 出版年: | Clin Pharmacokinet |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584252/ https://ncbi.nlm.nih.gov/pubmed/30854591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-019-00738-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|